KHENI BRASSO, APRN-FNP
Family Nurse Practitioner · TULSA, OK
Individual Active NPI 1205398617
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 876 | 729,300 | $20,177,627 | $9,830,115 | $7,818,854 |
| 2023 | 372 | 233,062 | $9,275,910 | $4,678,680 | $3,721,893 |
| 2022 | 125 | 77,315 | $3,858,036 | $2,196,585 | $1,751,344 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0174 | Injection, lecanemab-irmb, 1 mg | 315,860 | $1 | $1 |
| J1306 | Injection, inclisiran, 1 mg | 105,364 | $12 | $9 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 56,910 | $11 | $9 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 31,500 | $1 | $1 |
| J0897 | Injection, denosumab, 1 mg | 18,540 | $25 | $20 |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 17,850 | $17 | $14 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 16,800 | $12 | $9 |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 15,600 | $17 | $14 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 8,700 | $17 | $14 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,700 | $43 | $34 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 2,560 | $0 | $0 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,480 | $29 | $23 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | 109661 | OK |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in Oklahoma
- NPI 1073091062
- NPI 1265163810
- NPI 1689254609
- NPI 1316741101
- NPI 1427630102
- NPI 1508692732
- NPI 1205485984
- NPI 1770115420
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.